Literature DB >> 11090235

Vertebral fractures in osteoporosis: a new method for clinical assessment.

H K Genant1, J Li, C Y Wu, J A Shepherd.   

Abstract

Vertebral fractures are the most common consequence of osteoporosis, and are an important risk factor for subsequent fractures. Patients with reduced bone mineral density (BMD) and vertebral fractures have significantly increased risk for future fractures, indicating great potential for the combined use of fracture assessment and BMD in risk evaluation. Despite the established importance of fractures, however, vertebral assessment is not typically performed in the clinical evaluation of patients at risk for osteoporosis. Radiographs are the accepted standard for assessment of fractures, but are rarely obtained in osteoporosis assessment for a variety of practical reasons, including cost, radiation dose, and the lack of office-based radiological facilities. Clinical assessment of fractures is difficult because most are asymptomatic. Consequently, this strong risk factor for osteoporotic fractures is often overlooked. High-resolution lateral spine images, obtained on advanced fan-beam dual X-ray absorptiometry (DXA) systems, provide a practical, low-radiation dose, point-of-care methodology for assessment of vertebral fractures, and have the potential to address this important clinical need. In this article, we review the importance of vertebral fractures and the methods of assessing them. We also review clinical data supporting the feasibility of visual evaluation of lateral spine images obtained using a fan-beam DXA system, and discuss the potential positive impact of this new methodology on clinical patient evaluation.

Entities:  

Mesh:

Year:  2000        PMID: 11090235     DOI: 10.1385/jcd:3:3:281

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  56 in total

1.  Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women.

Authors:  L J Melton; D E Wenger; E J Atkinson; S J Achenbach; T H Berquist; B L Riggs; G Jiang; R Eastell
Journal:  Osteoporos Int       Date:  2006-04-28       Impact factor: 4.507

2.  A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis.

Authors:  J H Krege; K Siminoski; J D Adachi; D A Misurski; P Chen
Journal:  Osteoporos Int       Date:  2005-11-22       Impact factor: 4.507

3.  Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.

Authors:  H A Rudman; F Birrell; M S Pearce; S P Tuck; R M Francis; L Treadgold; K Hind
Journal:  Osteoporos Int       Date:  2019-01-08       Impact factor: 4.507

Review 4.  Detection of vertebral fractures.

Authors:  Elliott N Schwartz; Dee Steinberg
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

5.  Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness.

Authors:  P Lakatos; E Tóth; L Szekeres; G Poór; G Héjj; I Marton; I Takács
Journal:  Osteoporos Int       Date:  2014-05-13       Impact factor: 4.507

Review 6.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

7.  Performance of calcaneus quantitative ultrasound and dual-energy X-ray absorptiometry in the discrimination of prevalent asymptomatic osteoporotic fractures in postmenopausal women.

Authors:  A El Maghraoui; F Morjane; A Mounach; M Ghazi; A Nouijai; L Achemlal; A Bezza; I Ghozlani
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

8.  Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Authors:  I A Campbell; J G Douglas; R M Francis; R J Prescott; D M Reid
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

9.  Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.

Authors:  Bruno Frediani; Ilaria Bertoldi; Serena Pierguidi; Antonella Nicosia; Valentina Picerno; Georgios Filippou; Luca Cantarini; Mauro Galeazzi
Journal:  Clin Drug Investig       Date:  2013-03       Impact factor: 2.859

Review 10.  Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice.

Authors:  Michael Maricic
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.